Toxicology Letters (ISSN 0378-4274, 1879-3169) is a journal published by Elsevier in Ireland. It covers Medicine, Pharmacology, Toxicology and Pharmaceutics and Medicine (miscellaneous). It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 3.1, Scopus Q2, Web of Science Q2, CiteScore 5 and HEC W-Category. Article processing charge: USD 3,840.
Journal title
Toxicology Letters
ISSN
0378-4274, 1879-3169
Subject area
MedicinePharmacologyToxicology and PharmaceuticsMedicine (miscellaneous)Toxicology
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Scopus Quartile
Q2
WoS Quartile
Q2
Impact Factor
3.1
Country
Ireland
Publisher
Elsevier
SJR
0.724
Open access
No
APC (USD)
3840
About the journal
Official Journal of EUROTOX Affiliated with Austrian Society of Toxicology An international journal for the rapid publication of novel reports on a range of aspects of toxicology, especially mechanisms of toxicity. Toxicology Letters serves as a multidisciplinary forum for research in toxicology. The prime aim is the rapid publication of research studies that are both novel and advance our understanding of a particular area. In addition to hypothesis-driven studies on mechanisms of mammalian toxicity, Toxicology Letters welcomes seminal work in the following areas: In silico toxicology Toxicokinetics Physiologically-based pharmacokinetic (PBPK) modeling Systems toxicology Predictive toxicology 3R research in toxicology New approach methodology (NAMs) Adverse outcome pathways (AOPs) Integrated testing strategies Systematic and narrative reviews and mini-reviews in various areas of toxicology will be published. Clinical, occupational and safety evaluation, hazard and risk assessment, regulatory toxicology, impact on man, animal and environment studies of sufficient novelty to warrant rapid publication will be considered. Toxicology Letters also publishes editorials, commentaries and contemporary issues in toxicology. The following types of work are not within the scopes of Toxicology Letters: Ecotoxicology studies Case studies Chemoprevention studies Pharmacological investigations Authors are advised to follow the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments; https://arriveguidelines.org/) and the OECD guidance document on Good In Vitro Method Practices (GIVIMP; https://www.oecd.org/env/guidance-document-on-good-in-vitro-method-practices-givimp-9789264304796-en.htm). In vitro or in vivo investigations conducted at concentrations or doses of no relevance to human or animal exposure will not be considered. Routes of exposure other than those relevant to human or animal exposure need to be justified. Assessment of dose-response should be an integral component of any toxicological research report. Unless adequately justified, studies conducted at a single dose level may not be considered. Test materials must be chemically defined and characterized. Investigations of chemically undefined plant extracts or uncharacterized nanoparticles will not be considered.
Aims and Scope
Official Journal of EUROTOX Affiliated with Austrian Society of Toxicology An international journal for the rapid publication of novel reports on a range of aspects of toxicology, especially mechanisms of toxicity. Toxicology Letters serves as a multidisciplinary forum for research in toxicology. The prime aim is the rapid publication of research studies that are both novel and advance our understanding of a particular area. In addition to hypothesis-driven studies on mechanisms of mammalian toxicity, Toxicology Letters welcomes seminal work in the following areas: In silico toxicology Toxicokinetics Physiologically-based pharmacokinetic (PBPK) modeling Systems toxicology Predictive toxicology 3R research in toxicology New approach methodology (NAMs) Adverse outcome pathways (AOPs) Integrated testing strategies Systematic and narrative reviews and mini-reviews in various areas of toxicology will be published. Clinical, occupational and safety evaluation, hazard and risk assessment, regulatory toxicology, impact on man, animal and environment studies of sufficient novelty to warrant rapid publication will be considered. Toxicology Letters also publishes editorials, commentaries and contemporary issues in toxicology. The following types of work are not within the scopes of Toxicology Letters: Ecotoxicology studies Case studies Chemoprevention studies Pharmacological investigations Authors are advised to follow the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments; https://arriveguidelines.org/) and the OECD guidance document on Good In Vitro Method Practices (GIVIMP; https://www.oecd.org/env/guidance-document-on-good-in-vitro-method-practices-givimp-9789264304796-en.htm). In vitro or in vivo investigations conducted at concentrations or doses of no relevance to human or animal exposure will not be considered. Routes of exposure other than those relevant to human or animal exposure need to be justified. Assessment of dose-response should be an integral component of any toxicological research report. Unless adequately justified, studies conducted at a single dose level may not be considered. Test materials must be chemically defined and characterized. Investigations of chemically undefined plant extracts or uncharacterized nanoparticles will not be considered.
Yes. The catalogue records Toxicology Letters in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Toxicology Letters indexed in Scopus?
Yes. Toxicology Letters is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 5. Check its current status on the Scopus Sources page.
Is Toxicology Letters in Web of Science?
Yes. Toxicology Letters is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.
What is the impact factor of Toxicology Letters?
The recorded journal impact factor of Toxicology Letters is 3.1. Clarivate updates impact factors every year in Journal Citation Reports.
Is Toxicology Letters open access, and what does it charge?
Toxicology Letters is not recorded as fully open access and its APC is USD 3,840. Fees change, so check the journal's website before you submit.
Who publishes Toxicology Letters?
Toxicology Letters is published by Elsevier in Ireland, under ISSN 0378-4274 and 1879-3169.
Research profile
32,282articles indexed
442,726citations
209h-index
0.512-year mean citedness
1877first year indexed
Main research topics: Carcinogens and Genotoxicity Assessment, Immunotoxicology and immune responses, Pesticide Exposure and Toxicity, Heavy Metal Exposure and Toxicity, Environmental Toxicology and Ecotoxicology, Effects and risks of endocrine disrupting chemicals.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.